Tyra Historical Income Statement
| TYRA Stock | USD 12.20 0.17 1.41% |
Historical analysis of Tyra Biosciences income statement accounts such as Total Revenue of 0.0, Other Operating Expenses of 96.5 M, Research Development of 75.1 M or Cost Of Revenue of 426.2 K can show how well Tyra Biosciences performed in making a profits. Evaluating Tyra Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Tyra Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Tyra Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tyra Biosciences is a good buy for the upcoming year.
Tyra |
About Tyra Income Statement Analysis
Tyra Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tyra Biosciences shareholders. The income statement also shows Tyra investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Tyra Biosciences Income Statement Chart
Add Fundamental
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Tyra Biosciences minus its cost of goods sold. It is profit before Tyra Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Tyra Biosciences. It is also known as Tyra Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Tyra Biosciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Tyra Biosciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Tyra Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Tyra Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tyra Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.At present, Tyra Biosciences' Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Depreciation And Amortization is expected to grow to about 426.2 K, whereas Gross Profit is projected to grow to (301.8 K).
| 2022 | 2024 | 2025 (projected) | Interest Expense | 296K | 340.4K | 357.4K | Depreciation And Amortization | 296K | 406.0K | 426.2K |
Tyra Biosciences income statement Correlations
Click cells to compare fundamentals
Tyra Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tyra Biosciences income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 47K | 140K | 296K | 353K | 406.0K | 426.2K | |
| Selling General Administrative | 2.1M | 5.7M | 15.9M | 17.4M | 20.0M | 21.0M | |
| Gross Profit | (47K) | (140K) | (296K) | (353K) | (317.7K) | (301.8K) | |
| Other Operating Expenses | 9.3M | 26.3M | 58.9M | 79.9M | 91.9M | 96.5M | |
| Operating Income | (9.3M) | (26.3M) | (58.9M) | (79.9M) | (72.0M) | (68.4M) | |
| Net Income From Continuing Ops | (9.3M) | (26.3M) | (55.3M) | (69.1M) | (62.2M) | (59.1M) | |
| Ebit | (9.3M) | (26.3M) | (58.9M) | (79.9M) | (72.0M) | (68.4M) | |
| Research Development | 7.2M | 20.6M | 43.0M | 62.2M | 71.5M | 75.1M | |
| Ebitda | (9.3M) | (26.1M) | (58.6M) | (79.6M) | (71.6M) | (68.1M) | |
| Cost Of Revenue | 47K | 140K | 296K | 353K | 406.0K | 426.2K | |
| Total Operating Expenses | 9.3M | 26.3M | 58.9M | 79.9M | 91.9M | 96.5M | |
| Reconciled Depreciation | 47K | 140K | 296K | 353K | 406.0K | 426.2K | |
| Income Before Tax | (9.3M) | (26.3M) | (55.3M) | (69.1M) | (62.2M) | (59.1M) | |
| Total Other Income Expense Net | (39K) | (6K) | 3.6M | 10.8M | 12.4M | 13.1M | |
| Net Income | (9.3M) | (26.1M) | (51.7M) | (69.1M) | (62.2M) | (59.1M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tyra Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tyra Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tyra Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tyra Biosciences Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tyra Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tyra Biosciences. If investors know Tyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tyra Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tyra Biosciences is measured differently than its book value, which is the value of Tyra that is recorded on the company's balance sheet. Investors also form their own opinion of Tyra Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Tyra Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tyra Biosciences' market value can be influenced by many factors that don't directly affect Tyra Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tyra Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tyra Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tyra Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.